Shanghai Rongtai Health Tech (603579) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.007x

Based on the latest financial reports, Shanghai Rongtai Health Tech (603579) has a cash flow conversion efficiency ratio of -0.007x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-18.37 Million ≈ $-2.69 Million USD) by net assets (CN¥2.75 Billion ≈ $402.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanghai Rongtai Health Tech - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Shanghai Rongtai Health Tech's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Shanghai Rongtai Health Tech debt and liabilities for a breakdown of total debt and financial obligations.

Shanghai Rongtai Health Tech Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Rongtai Health Tech ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Mersen SA
PA:MRN
0.083x
Zhejiang Jianye Chemical Co Ltd
SHG:603948
0.047x
Arko Corp
NASDAQ:ARKO
0.121x
Tyntek Corp
TW:2426
0.005x
SG Corporation
KO:004060
0.033x
Afcon Holdings Ltd
TA:AFHL
0.022x
AmRest Holdings SE
MC:EAT
0.278x
Mnc Land Tbk
JK:KPIG
0.018x

Annual Cash Flow Conversion Efficiency for Shanghai Rongtai Health Tech (2011–2024)

The table below shows the annual cash flow conversion efficiency of Shanghai Rongtai Health Tech from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Shanghai Rongtai Health Tech.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.02 Billion
≈ $294.95 Million
CN¥168.14 Million
≈ $24.60 Million
0.083x -52.20%
2023-12-31 CN¥1.97 Billion
≈ $288.71 Million
CN¥344.29 Million
≈ $50.38 Million
0.175x +37.82%
2022-12-31 CN¥1.87 Billion
≈ $273.65 Million
CN¥236.79 Million
≈ $34.65 Million
0.127x -33.30%
2021-12-31 CN¥1.78 Billion
≈ $260.49 Million
CN¥337.92 Million
≈ $49.45 Million
0.190x +13.67%
2020-12-31 CN¥1.65 Billion
≈ $241.49 Million
CN¥275.59 Million
≈ $40.33 Million
0.167x -38.98%
2019-12-31 CN¥1.63 Billion
≈ $238.73 Million
CN¥446.47 Million
≈ $65.33 Million
0.274x +56.87%
2018-12-31 CN¥1.50 Billion
≈ $219.23 Million
CN¥261.35 Million
≈ $38.24 Million
0.174x -14.18%
2017-12-31 CN¥1.38 Billion
≈ $202.40 Million
CN¥281.17 Million
≈ $41.14 Million
0.203x -47.10%
2016-12-31 CN¥457.14 Million
≈ $66.89 Million
CN¥175.68 Million
≈ $25.71 Million
0.384x -43.99%
2015-12-31 CN¥312.77 Million
≈ $45.77 Million
CN¥214.60 Million
≈ $31.40 Million
0.686x +7.05%
2014-12-31 CN¥195.25 Million
≈ $28.57 Million
CN¥125.14 Million
≈ $18.31 Million
0.641x +8.98%
2013-12-31 CN¥130.52 Million
≈ $19.10 Million
CN¥76.76 Million
≈ $11.23 Million
0.588x +989.43%
2012-12-31 CN¥141.94 Million
≈ $20.77 Million
CN¥7.66 Million
≈ $1.12 Million
0.054x +92.95%
2011-12-31 CN¥133.29 Million
≈ $19.50 Million
CN¥3.73 Million
≈ $545.68K
0.028x --

About Shanghai Rongtai Health Tech

SHG:603579 China Leisure
Market Cap
$656.07 Million
CN¥4.48 Billion CNY
Market Cap Rank
#11182 Global
#3330 in China
Share Price
CN¥22.30
Change (1 day)
+0.68%
52-Week Range
CN¥19.32 - CN¥43.26
All Time High
CN¥71.85
About

Shanghai Rongtai Health Technology Corporation Limited, together with its subsidiaries, engages in the research, design, development, production, and sale of massage equipment under the Rongtai and Momoda brands in China and internationally. The company offers massage chairs and accessories, neck massagers, eye massagers, massage backrests, massage belts, foot massagers, massage pads, and handhel… Read more